Semax and Selank are Russian-derived nootropic peptides studied for different cognitive goals. Semax sharpens focus by elevating BDNF. Selank calms anxiety via GABA modulation. Both are available at TelosRX, subject to medical approval by a licensed provider.
If you've spent time in the research peptide space, you've encountered the Semax vs Selank debate. The comparison makes sense—both are well-studied, both are administered intranasally, and both come from Russian pharmacological research spanning decades. But they solve different problems.
One sharpens your mind. The other steadies your nerves. Understanding that difference saves you from choosing the wrong tool for the wrong job—and from expecting outcomes neither peptide is designed to deliver.
What Is Semax?
Semax is a synthetic analog of ACTH(4-10), a fragment of adrenocorticotropic hormone. Researchers at the Institute of Molecular Genetics in Moscow developed it in the 1980s. It's registered in Russia as a nootropic pharmaceutical and has been studied in the context of stroke recovery, attention-related cognitive deficits, and ischemic brain injury.
Its primary mechanism involves upregulating brain-derived neurotrophic factor (BDNF)—a protein central to neuron survival, synaptic plasticity, and memory consolidation. Preclinical studies show Semax elevates BDNF and upregulates TrkB receptor density in the prefrontal cortex—the region most closely tied to working memory and executive function. In animal studies, detectable BDNF elevations persist for 24 hours or more after a single dose, suggesting effects that outlast the peptide's presence in circulation.
This neurotrophic effect differs from classical stimulants. Rather than forcing more output from existing neural pathways, Semax appears to support the structural conditions for better cognition over time. Semax also modulates dopaminergic and serotonergic pathways, contributing to its stimulating, pro-cognitive profile.
Research subjects describe improved mental clarity, faster information retrieval, and stronger sustained attention—often using it in cycles rather than as a single-dose daily stimulant. For a deeper look at the mechanism and research context, see our Semax research guide.
Semax has attracted growing interest outside Russia partly because of its relatively narrow side effect profile compared to classical nootropics. It doesn't carry the cardiovascular or dependency risks associated with amphetamine-based cognitive enhancers. Its mechanism—building neurological capacity rather than depleting a neurochemical reservoir—makes it a research subject of ongoing interest for attention and recovery contexts.
What Is Selank?
Selank is a synthetic heptapeptide derived from tuftsin, a natural immune-modulating tetrapeptide found in immunoglobulin G. Like Semax, it emerged from Soviet-era pharmacological research at the Institute of Molecular Genetics in Moscow. It's registered in Russia as an anxiolytic—a medicine that reduces anxiety without producing sedation.
Where Semax activates, Selank steadies. Its primary mechanism is GABAergic modulation. GABA is the brain's main inhibitory neurotransmitter. By enhancing its activity, Selank reduces the excessive neural excitation associated with anxiety, chronic stress, and emotional dysregulation. Research has compared its anxiolytic effect profile to benzodiazepines, but without the sedation, tolerance, or dependence that defines that drug class.
Selank also influences the expression of serotonin-related genes, contributing to its mood-stabilizing profile. Animal studies show it can partially reverse stress-induced memory impairments—suggesting its anxiolytic and cognitive benefits may overlap more than they first appear. Our full Selank research guide covers the anxiolytic mechanism in more depth.
Semax vs Selank: Head-to-Head Comparison
The clearest way to understand these two peptides is side by side. The table below highlights their complementary nature—where one is strong, the other often fills the gap:
| Feature | Semax | Selank |
|---|---|---|
| Primary mechanism | BDNF upregulation, dopaminergic and serotonergic modulation | GABAergic modulation, serotonin gene expression |
| Main studied use | Focus, working memory, neuroplasticity | Anxiety reduction, stress resilience, emotional stability |
| Subjective profile | Mentally energizing, sharp, stimulating | Calm, emotionally even, grounded |
| Administration route | Intranasal | Intranasal |
| Studied dose range | 200–600 mcg per dose | 250–500 mcg per dose |
| Common side effects | Nasal irritation; possible overstimulation at higher doses | Nasal irritation; mild sedation in some subjects |
| FDA status | Not FDA-approved | Not FDA-approved |
| Stacking | Commonly paired with Selank | Commonly paired with Semax |
Which Is Better for Focus?
Semax is the more directly pro-cognitive option. Its BDNF-elevating mechanism supports the neural infrastructure of sustained attention and working memory. The dopaminergic component adds motivational drive—often as valuable as raw cognitive capacity for people who struggle to initiate or maintain focused work.
This isn't a caffeine-style jolt that crashes. It's a mechanism that builds the conditions for better cognition. That's why many people use Semax in multi-week cycles rather than daily single doses.
Selank can contribute to focus, but only indirectly. If your mental fog is anxiety-driven—constant rumination, racing thoughts, chronic stress consuming cognitive bandwidth—Selank's calming effect may clear enough space to think clearly. It reduces noise that's interfering with your existing cognitive capacity. It doesn't add new cognitive capacity directly.
If focus is your primary goal and anxiety is not a significant factor, Semax is the more targeted choice. If anxiety is the underlying driver of your attention problems, Selank may address the real issue more directly than a stimulating peptide would.
Which Is Better for Anxiety?
Selank wins this category clearly. Its GABAergic mechanism targets excess excitatory neural activity—the biological substrate of anxiety. It does so without the dependence and withdrawal problems that make benzodiazepines a long-term liability for many people.
Semax can worsen anxiety in some individuals at higher doses. Its dopaminergic activity is stimulating. If you're already anxiety-prone, that stimulation can tip into jitteriness or irritability rather than productive energy. Starting at lower doses matters with Semax—but if anxiety is the primary concern, Selank is a more appropriate starting point.
Can You Stack Semax and Selank?
Yes—and this is one of the more common protocols in nootropic peptide research. The rationale is mechanistic: these two peptides complement rather than duplicate each other. Semax provides the cognitive activation; Selank moderates the excitatory edge that can come with it.
People who use both often describe a more balanced experience. They report the mental sharpness of Semax without occasional overstimulation. They get emotional stability from Selank without cognitive blunting. Preclinical research noted additive effects on cognitive performance when both were co-administered, though human data remains limited.
If you're researching other cognitive peptides alongside these, Dihexa (studied for synaptic plasticity) and Cerebrolysin (a neurotrophin-rich preparation) are two more options with studied neurological mechanisms. Any async evaluation at TelosRX considers your full clinical picture before recommending a protocol.
Who Should Consider Each Peptide?
Semax may be worth researching if you're dealing with:
- Difficulty sustaining focus or attention for extended cognitive tasks
- Slow information retrieval or working memory issues not explained by anxiety
- Interest in neuroplasticity support alongside cognitive performance
- A lower-anxiety baseline where dopaminergic stimulation is unlikely to backfire
Selank may be worth researching if you're dealing with:
- Persistent anxiety or chronic stress that disrupts daily function
- Cognitive fog clearly driven by rumination or emotional overwhelm
- Interest in benzodiazepine alternatives without dependency risk
- A desire for mood stabilization without sedation or cognitive blunting
If you're uncertain which category you fall into, starting with one peptide, establishing a baseline response, and adding the second later is a common approach. Both may be relevant if anxiety and cognitive performance are meaningfully intertwined—which is more common than most people realize.
Dosage and Administration Guide
Both Semax and Selank are administered intranasally. This bypasses first-pass hepatic metabolism—the liver's rapid breakdown of orally ingested peptides—and allows them to enter systemic circulation more efficiently. The nasal mucosa provides a direct vascular pathway that makes intranasal delivery standard for both compounds in research settings.
Dose ranges documented in research:
- Semax: 200–600 mcg per dose is the most commonly cited range in studied protocols. Lower doses are preferred initially. Research shows BDNF effects are dose-dependent, with diminishing returns and increased side effect risk at higher doses. Some protocols use once-daily morning dosing to avoid sleep disruption.
- Selank: 250–500 mcg per dose appears in most anxiolytic studies. Some protocols use twice-daily administration to maintain steadier anxiolytic coverage, particularly for subjects with persistent generalized anxiety.
These figures come from preclinical studies and limited human trials. They don't constitute medical dosing advice. Any evaluation at TelosRX is asynchronous—no phone or video appointment required. If a licensed provider approves your request, dosing guidance is specific to your health history and stated goals.
Side Effects and Safety Profile
Both peptides show favorable tolerability in published research. The adverse event profile is narrow compared to many pharmaceutical anxiolytics or stimulants. That said, the safety picture has real gaps worth understanding before making a decision.
Nasal irritation is the most consistent finding—an expected consequence of intranasal peptide administration, not a specific pharmacological effect of either compound.
Beyond that, the profiles diverge:
- Semax: At higher doses, some subjects experience mild transient anxiety, headache, or disrupted sleep when dosed late in the day. Animal studies noted transient glucose metabolism changes. These effects appear dose-dependent and reversible with dose reduction or timing adjustments.
- Selank: Mild sedation is possible in some individuals, particularly at higher doses or when combined with other calming agents. No tolerance or dependence signal has emerged in research—a meaningful distinction from benzodiazepines or other classical GABA-targeting drugs.
Critical limitation: long-term human safety data is sparse for both peptides. Most studies are short-duration, conducted in Russian clinical settings, and lack the longitudinal follow-up that characterizes modern pharmaceutical trials. Both Semax and Selank are not FDA-approved. Compounded formulations haven't undergone the pharmaceutical-grade safety review that approved medications require.
The FDA has specifically raised concerns about compounded nootropic peptides, including limited immunogenicity data and peptide impurity risks. That context doesn't invalidate the research—but it belongs in the decision.
Legal Status and Research Context
In the United States, neither Semax nor Selank holds FDA approval for any indication. They're not scheduled controlled substances, so possession is generally not prohibited. But their sale for human use occupies a regulatory gray area that continues to evolve as compounding pharmacy oversight tightens.
In Russia, both are registered pharmaceutical products—Semax as a nootropic, Selank as an anxiolytic—with decades of clinical prescribing history. The existing human evidence base is substantial by research-peptide standards. But it's concentrated in a clinical and regulatory context that differs from US standards and manufacturing requirements.
Each state may have different telehealth regulations governing what compounds can be prescribed and dispensed remotely. TelosRX operates as an online-first, asynchronous telehealth platform. The evaluation process happens through async messaging with a licensed provider—no real-time phone or video required. Approval is not guaranteed, and each case is evaluated individually based on your health history and stated goals.
One practical point: TelosRX’s async model means no waiting room, no scheduled appointments. You complete a detailed intake form covering your health history, current medications, and goals. A licensed provider reviews it and either approves a compound, declines, or requests clarification—all through secure async messaging. This is the evaluation process that satisfies the provider-gate requirement before any compounded peptide is dispensed.
Frequently Asked Questions
Which is better for anxiety, Semax or Selank?
Selank is the more studied choice for anxiety. Its GABAergic mechanism produces anxiolytic effects comparable to benzodiazepines in preclinical and limited human research, without sedation or dependency risk. Semax at higher doses can increase anxiety in some individuals due to its dopaminergic activity. For anxiety-predominant presentations, Selank is the more appropriate starting point.
Which is better for focus, Semax or Selank?
Semax is the more directly pro-cognitive option. It upregulates BDNF in the prefrontal cortex and modulates dopamine signaling, supporting sharper attention and working memory in studied protocols. Selank can improve focus indirectly—by reducing anxiety-driven cognitive interference—but it doesn't directly enhance neurotrophic activity or executive function circuits.
Can you stack Semax and Selank together?
Yes. Stacking is a common protocol in the research community. The mechanisms are complementary: Semax provides cognitive activation while Selank moderates excitatory side effects. Limited preclinical evidence suggests additive cognitive benefits with co-administration. Any stacking protocol should begin with an evaluation by a licensed provider—timing and dosing decisions matter.
Are Semax and Selank FDA-approved?
Neither is FDA-approved for any indication in the United States. Both are registered medicines in Russia with decades of clinical use, but they haven't completed the large-scale, placebo-controlled trials required for FDA drug approval. Compounded formulations are not FDA-approved and carry additional regulatory uncertainty compared to approved pharmaceuticals.
How are Semax and Selank administered?
Both are typically administered intranasally using a dropper or spray. This route improves bioavailability compared to oral administration and allows more direct access to systemic circulation. Intranasal delivery bypasses first-pass liver metabolism, which degrades peptides before they can exert their effects.
What are the side effects of Semax and Selank?
Nasal irritation is the most consistently reported side effect of both peptides. Semax may cause headache, mild overstimulation, or disrupted sleep if dosed late in the day. Selank may produce mild sedation in some subjects, particularly at higher doses. Neither has demonstrated dependence potential in available research. Long-term human safety data is limited for both compounds.
Is Semax or Selank better for brain fog?
It depends on the underlying cause. If your brain fog is anxiety-driven—mental noise from chronic stress or rumination—Selank's calming mechanism may address the root problem. If it stems from low cognitive energy, attention difficulties, or neurotrophic deficit, Semax is more directly studied for that profile. Some people find the combination addresses both simultaneously.
How long does it take for Semax or Selank to work?
Many research subjects report subjective onset within 30–60 minutes of intranasal administration. Single-dose effects typically last 4–8 hours based on reported protocols. Cumulative neurotrophic effects from Semax—particularly BDNF elevation—may take several weeks of repeated administration to become measurable in animal models. Individual response varies based on baseline status, dosing, and administration technique.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.